| Product Code: ETC7763306 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Jordan Lumasiran Market Overview |
3.1 Jordan Country Macro Economic Indicators |
3.2 Jordan Lumasiran Market Revenues & Volume, 2021 & 2031F |
3.3 Jordan Lumasiran Market - Industry Life Cycle |
3.4 Jordan Lumasiran Market - Porter's Five Forces |
3.5 Jordan Lumasiran Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Jordan Lumasiran Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Jordan Lumasiran Market Revenues & Volume Share, By Dosage form, 2021 & 2031F |
3.8 Jordan Lumasiran Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Jordan Lumasiran Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Jordan Lumasiran Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Jordan Lumasiran Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of rare genetic diseases, specifically Primary Hyperoxaluria Type 1 (PH1), the target condition for Jordan Lumasiran. |
4.2.2 Growing awareness about RNA interference (RNAi) therapy as a treatment option for genetic diseases. |
4.2.3 Favorable regulatory environment supporting the development and approval of innovative therapies like Jordan Lumasiran. |
4.3 Market Restraints |
4.3.1 High cost associated with RNAi therapies may limit access to Jordan Lumasiran for some patients. |
4.3.2 Competition from other emerging RNAi therapies targeting similar rare genetic diseases. |
4.3.3 Potential challenges in patient identification and diagnosis of Primary Hyperoxaluria Type 1, impacting the market adoption of Jordan Lumasiran. |
5 Jordan Lumasiran Market Trends |
6 Jordan Lumasiran Market, By Types |
6.1 Jordan Lumasiran Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Jordan Lumasiran Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Jordan Lumasiran Market Revenues & Volume, By Miscellaneous Metabolic Agents, 2021- 2031F |
6.1.4 Jordan Lumasiran Market Revenues & Volume, By others, 2021- 2031F |
6.2 Jordan Lumasiran Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Jordan Lumasiran Market Revenues & Volume, By Primary Hyperoxaluria, 2021- 2031F |
6.2.3 Jordan Lumasiran Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Jordan Lumasiran Market, By Dosage form |
6.3.1 Overview and Analysis |
6.3.2 Jordan Lumasiran Market Revenues & Volume, By Injection, 2021- 2031F |
6.3.3 Jordan Lumasiran Market Revenues & Volume, By Solution, 2021- 2031F |
6.4 Jordan Lumasiran Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Jordan Lumasiran Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.4.3 Jordan Lumasiran Market Revenues & Volume, By Demographic, 2021- 2031F |
6.4.4 Jordan Lumasiran Market Revenues & Volume, By Adult, 2021- 2031F |
6.4.5 Jordan Lumasiran Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.5 Jordan Lumasiran Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Jordan Lumasiran Market Revenues & Volume, By Clinics, 2021- 2031F |
6.5.3 Jordan Lumasiran Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.4 Jordan Lumasiran Market Revenues & Volume, By Diagnostic center, 2021- 2031F |
6.6 Jordan Lumasiran Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Jordan Lumasiran Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Jordan Lumasiran Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Jordan Lumasiran Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Jordan Lumasiran Market Import-Export Trade Statistics |
7.1 Jordan Lumasiran Market Export to Major Countries |
7.2 Jordan Lumasiran Market Imports from Major Countries |
8 Jordan Lumasiran Market Key Performance Indicators |
8.1 Patient enrollment in clinical trials for Jordan Lumasiran, indicating interest and engagement from the medical community and patients. |
8.2 Adoption rate of Jordan Lumasiran in key markets, demonstrating acceptance and demand for the therapy. |
8.3 Patient-reported outcomes and quality of life improvements after receiving Jordan Lumasiran, showcasing the real-world impact of the treatment. |
9 Jordan Lumasiran Market - Opportunity Assessment |
9.1 Jordan Lumasiran Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Jordan Lumasiran Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Jordan Lumasiran Market Opportunity Assessment, By Dosage form, 2021 & 2031F |
9.4 Jordan Lumasiran Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Jordan Lumasiran Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Jordan Lumasiran Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Jordan Lumasiran Market - Competitive Landscape |
10.1 Jordan Lumasiran Market Revenue Share, By Companies, 2024 |
10.2 Jordan Lumasiran Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here